United Therapeutics Corporation
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2010 | $34.2M | $27.9M | $6.4M | $30.1M |
| Jun 2010 | $35.2M | $32.5M | $2.8M | $-370.0K |
| Sep 2010 | $102.8M | $98.7M | $4.1M | $31.4M |
| Dec 2010 | $39.3M | $33.8M | $5.4M | $52.8M |
| Mar 2011 | $53.4M | $47.0M | $6.3M | $36.9M |
| Jun 2011 | $64.5M | $52.0M | $12.5M | $-27.0M |
| Sep 2011 | $80.7M | $62.8M | $17.8M | $-47.6M |
| Dec 2011 | $51.6M | $52.4M | $-747.0K | $22.1M |
| Mar 2012 | $37.6M | $-2.7M | $40.3M | $-24.0K |
| Jun 2012 | $87.4M | $43.7M | $43.6M | $9.4M |
| Sep 2012 | $93.4M | $86.7M | $6.7M | $31.1M |
| Dec 2012 | $105.2M | $84.0M | $21.3M | $-10.5M |
| Mar 2013 | $97.7M | $93.5M | $4.2M | $35.2M |
| Jun 2013 | $83.8M | $79.0M | $4.8M | $33.0M |
| Sep 2013 | $139.3M | $129.9M | $9.4M | $74.4M |
| Dec 2013 | $104.4M | $91.0M | $13.4M | $178.2M |
| Mar 2014 | $110.6M | $91.9M | $18.7M | $-60.7M |
| Jun 2014 | $-54.5M | $-67.3M | $12.8M | $-1.9M |
| Sep 2014 | $208.5M | $194.9M | $13.6M | $220.3M |
| Dec 2014 | $90.6M | $88.4M | $2.2M | $32.4M |
| Mar 2015 | $109.1M | $105.1M | $4.0M | $234.5M |
| Jun 2015 | $41.0M | $37.2M | $3.8M | $47.3M |
| Sep 2015 | $207.2M | $196.7M | $10.5M | $-118.9M |
| Dec 2015 | $25.5M | $-6.0M | $31.5M | $117.4M |
| Mar 2016 | $125.8M | $122.0M | $3.8M | $-144.6M |
| Jun 2016 | $125.7M | $115.3M | $10.4M | $1.5M |
| Sep 2016 | $228.7M | $219.6M | $9.1M | $49.9M |
| Dec 2016 | $163.4M | $148.7M | $14.7M | $105.3M |
| Mar 2017 | $230.8M | $215.2M | $15.6M | $-19.1M |
| Jun 2017 | $70.7M | $49.8M | $20.9M | $-1.9M |
| Sep 2017 | $258.5M | $236.5M | $22.0M | $-24.0M |
| Dec 2017 | $-85.8M | $-113.6M | $27.8M | $118.5M |
| Mar 2018 | $275.7M | $238.1M | $37.6M | $-101.1M |
| Jun 2018 | $179.8M | $126.3M | $53.5M | $20.5M |
| Sep 2018 | $237.5M | $196.0M | $41.5M | $51.4M |
| Dec 2018 | $85.4M | $33.6M | $51.8M | $2.8M |
| Mar 2019 | $-627.4M | $-652.5M | $25.1M | $29.2M |
| Jun 2019 | $132.9M | $112.6M | $20.3M | $-37.2M |
| Sep 2019 | $185.4M | $171.8M | $13.6M | $23.9M |
| Dec 2019 | $102.5M | $77.8M | $24.7M | $29.5M |
| Mar 2020 | $214.6M | $201.6M | $13.0M | $30.8M |
| Jun 2020 | $164.0M | $145.8M | $18.2M | $51.8M |
| Sep 2020 | $250.9M | $235.1M | $15.8M | $-12.5M |
| Dec 2020 | $126.2M | $113.9M | $12.3M | $93.7M |
| Mar 2021 | $89.8M | $79.2M | $10.6M | $40.1M |
| Jun 2021 | $148.2M | $131.9M | $16.3M | $29.1M |
| Sep 2021 | $185.6M | $162.3M | $23.3M | $24.6M |
| Dec 2021 | $174.6M | $104.0M | $70.6M | $44.7M |
| Mar 2022 | $288.7M | $275.2M | $13.5M | $-21.1M |
| Jun 2022 | $127.0M | $110.0M | $17.0M | $65.5M |
| Sep 2022 | $258.6M | $189.8M | $68.8M | $-2.4M |
| Dec 2022 | $128.2M | $88.7M | $39.5M | $64.8M |
| Mar 2023 | $374.8M | $333.5M | $41.3M | $-12.4M |
| Jun 2023 | $106.3M | $61.6M | $44.7M | $13.8M |
| Sep 2023 | $346.2M | $280.5M | $65.7M | $21.1M |
| Dec 2023 | $150.7M | $72.0M | $78.7M | $16.6M |
| Mar 2024 | $376.5M | $338.3M | $38.2M | $25.6M |
| Jun 2024 | $232.2M | $187.1M | $45.1M | $49.7M |
| Sep 2024 | $377.2M | $300.7M | $76.5M | $41.7M |
| Dec 2024 | $341.2M | $254.5M | $86.7M | $27.0M |
| Mar 2025 | $461.2M | $386.3M | $74.9M | $31.8M |
| Jun 2025 | $191.7M | $129.5M | $62.2M | $37.8M |
| Sep 2025 | $562.1M | $351.6M | $210.5M | $39.1M |
| Dec 2025 | $346.2M | $173.3M | $172.9M | $39.0M |
| Mar 2026 | $463.3M | $362.5M | $100.8M | $33.9M |
| Jun 2026 | $313.6M | $205.6M | $108.0M | $43.4M |